These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20522140)

  • 1. The skinny on fat.
    Goldie MP
    Int J Dent Hyg; 2010 May; 8(2):150-2. PubMed ID: 20522140
    [No Abstract]   [Full Text] [Related]  

  • 2. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ
    Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
    [No Abstract]   [Full Text] [Related]  

  • 3. New therapeutic tool in diabetes management.
    Community Nurse; 2000 Dec; 6(11):6. PubMed ID: 11982176
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids.
    Huber J; Löffler M; Bilban M; Reimers M; Kadl A; Todoric J; Zeyda M; Geyeregger R; Schreiner M; Weichhart T; Leitinger N; Waldhäusl W; Stulnig TM
    Int J Obes (Lond); 2007 Jun; 31(6):1004-13. PubMed ID: 17130847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Xenical--a modern perspective drug for the treatment of obesity (review)].
    Mkrtumian AM; Biriukova EV
    Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143
    [No Abstract]   [Full Text] [Related]  

  • 7. [Altering lifestyle and treating obesity, preventing type 2 diabetes?].
    Sauvanet JP
    Soins; 2004 Apr; (684 Pt 2):19-24. PubMed ID: 15151088
    [No Abstract]   [Full Text] [Related]  

  • 8. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
    Opgenorth TJ
    Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101
    [No Abstract]   [Full Text] [Related]  

  • 9. Fat oxidation in obesity: druggable or risky enterprise?
    Clapham JC
    IDrugs; 2004 Mar; 7(3):238-42. PubMed ID: 15011098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orlistat.
    Wong NN; Cheng-Lai A
    Heart Dis; 2000; 2(2):174-81. PubMed ID: 11728255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orlistat in the treatment of NASH: a case series.
    Harrison SA; Ramrakhiani S; Brunt EM; Anbari MA; Cortese C; Bacon BR
    Am J Gastroenterol; 2003 Apr; 98(4):926-30. PubMed ID: 12738478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?].
    Ratziu V; Le Calvez S; Bonyhay L; Taieb J; Poynard T
    Gastroenterol Clin Biol; 2003 Oct; 27(10):869-75. PubMed ID: 14631300
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects.
    Ahnen DJ; Guerciolini R; Hauptman J; Blotner S; Woods CJ; Wargovich MJ
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1291-9. PubMed ID: 17920338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and strategies in managing cardiometabolic risk.
    Repas TB
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting fat absorption to halt weight gain.
    Lean M
    Practitioner; 1998 Dec; 242(1593):860-5. PubMed ID: 10441885
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and diabetes as a risk factor for hepatocellular carcinoma.
    Regimbeau JM; Colombat M; Mognol P; Durand F; Abdalla E; Degott C; Degos F; Farges O; Belghiti J
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat pill for teens. Xenical may have the FDA's blessing, but is it a good idea?
    Gupta S
    Time; 2003 Dec 29-2004 Jan 5; 162(26):162. PubMed ID: 14722944
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.